AKT1 and hepatocellular carcinoma: Huang et al. demonstrated that 3,3′5-tri-iodo-l-thyronine (T3) suppressed HCC cell proliferation through the inhibition of serine/threonine-protein kinase, PIM-1, via miRNA (miR-214-3p) [98].